INSIGHTS ON QUALITY CONTROL

• Pharmaceutical Labeling That Protects Product, Patient And Production

  Modern pharmaceutical labeling systems streamline serialization, tamper-evident sealing, and vision inspection to reduce line risk and maintain regulatory compliance across all production scales.

• Particle Data Collection And Interpretation For ISO Cleanrooms

  Transition from periodic sampling to continuous monitoring. Learn to establish risk-based alert limits and use N:M trending to maintain a true state of control in critical cleanroom zones.

• GMP Compliance In Pharmaceutical Manufacturing: Why Product Inspection Matters

  Learn how integrating advanced inspection technology—including X-ray systems, metal detectors, and checkweighers—can optimize your compliance strategy and protect product quality.

• Practical Considerations For Aseptic Gowning In Contamination Control Strategies (CCS)

  Personnel remain the most significant contributor to contamination risk. Explore these practical considerations for your CCS to address complex interactions between operators and their environment

• The Future Of QC Is Now

  5/5/2026

  Pharma Industry 4.0 is reaching microbiological quality control. See how automation and digital workflows are transforming manual QC processes, improving productivity, and reliability.

• Ask Us Anything: Erik Feldmann On Advancing Peptide Development

  7/24/2026

  Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.

• A Guide To Scale-Up And Purification For Small, Large Molecules

  4/13/2026

  Advance your separation and purification strategies by leveraging modern industrial chromatography approaches that scale reliably from lab to production across small-molecule and biologics manufacturing.

• Antibiotic Potency Testing By Microbial Assay

  9/24/2026

  Selecting a potency assay for antibiotic drug substances and products carries regulatory, operational, and lifecycle implications that extend well beyond the laboratory.

• Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres

  12/30/2024

  Biodegradable polymer microspheres control drug release through crystalline and amorphous properties, analyzed using DSC, MDSC, and TGA to determine composition and stability for precise delivery.